Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Background: Functional abdominal pain disorders (FAPD) are common in school-aged children;
however, there is no reliable treatment.
Aim: To determine the efficacy and safety of glucomannan for treating FAPD in children.
Trial Setting: Department of Pediatrics, The Medical University of Warsaw.
Intervention: Patients will be enrolled in a double-blind, randomized controlled trial in
which they will receive either glucomannan (10g) or placebo for 4 weeks.